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Summary
Multiple mechanisms have evolved to regulate the
eukaryotic genome. We have identified CTN-RNA, a
mouse tissue-specific w8 kb nuclear-retained poly(A)+
RNA that regulates the level of its protein-coding part-
ner. CTN-RNA is transcribed from the protein-coding
mouse cationic amino acid transporter 2 (mCAT2)
gene through alternative promoter and poly(A) site
usage. CTN-RNA is diffusely distributed in nuclei and
is also localized to paraspeckles. The 3 UTR of CTN-
RNA contains elements for adenosine-to-inosine edit-
ing, involved in its nuclear retention. Interestingly,
knockdown of CTN-RNA also downregulates mCAT2
mRNA. Under stress, CTN-RNA is posttranscription-
ally cleaved to produce protein-coding mCAT2 mRNA.
Our findings reveal a role of the cell nucleus in har-
boring RNA molecules that are not immediately needed
to produce proteins but whose cytoplasmic presence
is rapidly required upon physiologic stress. This mech-
anism of action highlights an important paradigm for
the role of a nuclear-retained stable RNA transcript in
regulating gene expression.
Introduction
In addition to harboring the cell’s genome, the nucleus
contains distinct substructures in the form of special-
ized domains/compartments that are characterized by
the absence of delineating membranes but that contain
defining sets of proteins (reviewed, Spector, 2001). A
dynamic interplay between these domains and/or their
constituents and the genome is thought to foster the
efficient progression of gene expression. Gene expres-
sion in eukaryotes is carried out through a series of
complex processes that includes transcription, pre-
mRNA processing, and export of mature mRNA to the
cytoplasm for translation. Recent evidence has indi-
cated that these processes are coordinated and can be
regulated at each level (reviewed, Maniatis and Reed,
2002). Changes in chromatin structure as well as in-
teractions between cis-DNA sequences and trans-act-
ing factors are required for the activation or silencing
of genes. In addition to constitutive gene expression,
transcription of specific genes can be induced in re-
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sponse to cell-cycle stage as well as several stimuli,
including stress and hormonal induction. Cotranscrip-
tional gene regulation can occur at the levels of 5#cap-
ping; constitutive and alternative pre-mRNA splicing;
polyadenylation; and, in some cases, RNA editing (re-
viewed, Bass, 2002; Orphanides and Reinberg, 2002).
Furthermore, translation can be tightly regulated at
either a global level or the level of specific mRNAs (i.e,
via miRNAs) (reviewed, Gebauer and Hentze, 2004; He
and Hannon, 2004).
The central dogma of molecular biology holds that
genetic information normally flows from DNA to RNA to
protein. As a consequence, it has been assumed that
genes generally encode for proteins and that proteins
fulfill not only structural and catalytic but also most reg-
ulatory functions in cells. However, a subset of RNAs
execute functions without being translated into protein.
Such RNAs include housekeeping RNAs (ribosomal
RNA, transfer RNA, and uridine-rich small nuclear and
nucleolar RNAs) and nuclear-retained RNAs that exe-
cute regulatory roles in various aspects of gene expres-
sion (Xist, Tsix, and Rian in mammals and hsr- -n and
roXs in Drosophila) (reviewed, Szymanski and Bar-
ciszewski, 2003). Interestingly, the percentage of non-
coding DNA in prokaryotes is <25% of the total ge-
nome compared to w98% in humans, most of which
contains active transcription units (Mattick, 2004). The
increased number of noncoding genes in multicellular
organisms is likely to provide more complexity to the
transcriptome.
An earlier study indicated that, in many cell types, a
considerable fraction of the poly(A)+ RNA (as much as
30%) is nuclear retained and undetectable in the cyto-
plasm (Herman et al., 1976). More recently, RNA fluores-
cence in situ hybridization (RNA-FISH) analysis using an
oligo dT probe in mammalian cells has shown that a
population of poly(A)+ RNA is enriched in nuclear
speckles, also known as interchromatin granule clus-
ters (IGCs) (Carter et al., 1991; Huang et al., 1994; Visa
et al., 1993). However, IGCs are not transcription sites;
rather, they are thought to be involved in the assembly/
modification and/or storage of the pre-mRNA process-
ing machinery (reviewed, Lamond and Spector, 2003).
The poly(A)+ RNA in the IGCs does not appear to be
transported to the cytoplasm (Huang et al., 1994), as
would be the case if they represented protein-coding
mRNAs, suggesting that this RNA or these RNAs con-
stitute new members of the nuclear regulatory RNA
(nrRNA) family.
In the present study, we biochemically purified IGCs
and associated nuclear domains from mouse liver nu-
clei and constructed a cDNA library from the poly(A)+
RNA. One of the cDNA clones localized in a micropunc-
tate nuclear distribution, and, in a population of cells,
it also localized to a subnuclear domain, paraspeckles
(Fox et al., 2002). Northern blot and genomic sequence
analysis revealed that this clone encodes a w8 kb
nuclear-retained poly(A)+ RNA, transcribed from the
mouse cationic amino acid transporter 2 (mCAT2) gene,
hence named CAT2 transcribed nuclear RNA (CTN-Cell
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RNA). The mCAT2 gene also encodes for the protein-
coding mCAT2 mRNA. However, each transcript pre-
dominantly utilizes a different promoter and has unique
untranslated regions (UTRs). The 3#UTR of CTN-RNA is
essential for its nuclear retention. Interestingly, CTN-
RNA is adenosine-to-inosine edited (A-to-I) in its 3#UTR.
Depleting CTN-RNA from cells using antisense oligonu-
cleotides resulted in downregulation of both CTN-RNA
and mCAT2 mRNA. Most interestingly, our results dem-
onstrated that, under stress conditions, CTN-RNA gets
posttranscriptionally cleaved at its 3#UTR, producing
an mRNA containing the mCAT2 coding region and a
unique 5#UTR, suggesting that CTN-RNA regulates the
levels of its protein-coding partner. This mechanism of
action brings to light an important paradigm for the role
of a nuclear-retained stable RNA transcript in regulating
gene expression.
Results
Characterization of a Nuclear-Retained
poly(A)+ RNA
In order to characterize the population of poly(A)+ RNA
enriched in nuclear IGCs and associated nuclear do-
mains, we biochemically purified the IGC fraction from
mouse liver nuclei (Mintz et al., 1999; Saitoh et al.,
2004), isolated poly(A)+ RNA, and constructed a plas-
mid-based cDNA library. Of the 2   103 clones screened,
over 1500 clones were sequenced and analyzed by a
blast similarity search of a nonredundant database
(http://www.ncbi.nlm.nih.gov). Clones which did not
show significant similarity to protein-coding genes
were further characterized by RNA-FISH in various
mouse cell lines. One of the clones, named CTN-RNA
(w700 bp in length), showed a diffuse micropunctate
nuclear distribution in mouse NIH 3T3 cells (Figure 1A)
and was excluded from the nucleoli (see Figures S5B–
S5B$ in the Supplemental Data available with this arti-
cle online). In addition, in about 25%–30% of the cells,
CTN-RNA also localized in 10–20 distinct nuclear foci
(arrows in Figure 1A). A similar localization pattern of
CTN-RNA was also observed in mouse liver tissue sec-
tions (Figure 1Ba) and primary mouse embryonic fibro-
blasts (wt MEFs; Figure S1). Specificity of the RNA-
FISH was confirmed by either hybridizing with vector
plasmid alone or RNase A pretreatment prior to hybrid-
ization (Figure S2). This restricted nucleoplasmic local-
ization of CTN-RNA was reminiscent of the distribution
of nuclear regulatory RNAs (reviewed, Szymanski and
Barciszewski, 2003), as protein-coding mRNAs gen-
erally localize as one to two intranuclear dots (the sites
of transcription) and a diffuse nuclear and cytoplasmic
distribution.
Northern blot analysis using the partial CTN-RNA
cDNA probe (w700 bp) revealed that CTN-RNA en-
codes a >8 kb transcript that is significantly enriched
in mouse liver compared to primary and transformed
mouse fibroblast cell lines (Figure 1C and Figure S3).
To corroborate the nuclear enrichment of CTN-RNA ob-
served by RNA-FISH, we isolated total RNA from
nuclear and cytoplasmic fractions of mouse mammary
tumor cells (C127I), which showed elevated levels of
expression (Figure S3), and carried out Northern hy-
bridization with the CTN-RNA probe. Such analysis
confirmed that CTN-RNA was predominantly present in
the nuclear fraction (Figure 1D). Furthermore, mouse
tissue Northern analysis revealed that CTN-RNA was
highly expressed in mouse liver, brain, and lung and
was not detectable in kidney and spleen (Figure 1E).
These results clearly indicated that CTN-RNA is a nu-
clear-localized poly(A)+ transcript with tissue-specific
expression.
CTN-RNA Is Transcribed from
a Protein-Coding Gene
The complete CTN-RNA cDNA was characterized by
RT-PCR using specific RT primers from the 700 bp 3#
end of the partial cDNA initially cloned, as well as by
mapping EST clones from the region. The overlapping
RT-PCR amplicons spanning the entire CTN-RNA were
cloned and sequenced. Complete sequence alignment
revealed that CTN-RNA is an w8 kb transcript and is
transcribed from the mCAT2 gene (Slc7a2; chromo-
some 8A4) (reviewed, MacLeod, 1996). The mCAT2
gene also encodes for w4.2 kb protein-coding cyto-
plasmic mCAT2 mRNA (Nicholson et al., 2001), whose
protein product is involved in the cellular uptake of cat-
ionic amino acids (reviewed, MacLeod, 1996). The pro-
tein-coding exons of the mCAT2 mRNA overlap with
CTN-RNA, and, in addition, all of the introns are com-
pletely spliced from both transcripts (Figure 2A). North-
ern hybridization using probes from various exons that
overlap between CTN-RNA and mCAT2 mRNA revealed
that they hybridize to both CTN-RNA and mCAT2 mRNA
(Figure 2B). However, sequence analysis revealed that
mCAT2 mRNA utilizes the first poly(A) site (AATAAA) in
exon 12, whereas CTN-RNA uses the distal poly(A) site
w4.5 kb downstream of the first poly(A) site, thereby
resulting in the production of a longer transcript.
The mCAT2 gene utilizes multiple promoters (A to E,
with each having unique exon 1 variants: exons 1A to
1E, comprising the 5#UTRs) in a tissue-specific manner
(Finley et al., 1995). RT-PCR analysis revealed that CTN-
RNA was exclusively transcribed by the distalmost pro-
moter A (Figure S4; for experimental details, see Sup-
plemental Experimental Procedures), whereas mCAT2
mRNA predominantly utilized promoter E in liver, C127I,
and primary and transformed fibroblasts and promoter
D in macrophage cells (Finley et al., 1995 and data not
shown). Promoter A, utilized by CTN-RNA, is a TATA-
less, CAAT-negative promoter with several high-affinity
SP1 and AP1 binding sites and CAC boxes, and, most
interestingly, it is located within a CpG island (Figure
2A; see also Finley et al., 1995). Sequence analysis re-
vealed that both promoters A and E contain seven ca-
nonical interferon response elements (IREs), consistent
with these promoters’ being induced as a result of
interferon activation (Nicholson et al., 2001 and data
not shown). Because of specific promoter usage and
poly(A) site selection, the nuclear-retained CTN-RNA
has a unique 5#UTR (w145 bp) and 3#UTR (w4.5 kb)
and the protein-coding mCAT2 mRNA has a unique
5#UTR (w483 bp). Therefore, in the case of the mCAT2
gene, promoter usage is linked to poly(A) site selection.
In order to study the cellular turnover of both CTN-
RNA and mCAT2 mRNA, total RNA was isolated from
untreated C127I cells; cells that were incubated with
 -amanitin, an RNA polymerase II inhibitor (irreversibleRegulating Gene Expression by RNA Nuclear Retention
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Figure 1. Characterization of CTN-RNA
(A and B) RNA-FISH to NIH 3T3 cells and mouse liver sections showing the diffuse nuclear localization of CTN-RNA and its distribution in
10–20 distinct foci (arrows). Scale bars equal 5  m.
(C) Northern blot analysis using a CTN-RNA cDNA probe to NIH 3T3 and mouse liver RNA shows that CTN-RNA encodes for a w8 kb
transcript.  -actin was used as loading control.
(D) Northern blot analysis of CTN-RNA in nuclear and cytoplasmic fractions from mouse mammary tumor cells (C127I) revealed that it is
enriched in nuclei. Ethidium-bromide-stained gel showing the levels of 28S and 18S rRNA as loading control.
(E) Tissue-specific expression profile of CTN-RNA by Northern blot analysis of various mouse tissues. RNA levels are depicted as a histogram
showing the highest level of expression of CTN-RNA in liver, brain, and lung.  -actin was used as loading control.
in tissue culture cells at 50  g/ml), for 6 hr; and also
from cells that were incubated for 3 and 9 hr in culture
medium post  -amanitin washout. RT-PCR using tran-
script-specific primer sets for CTN-RNA and mCAT2
mRNA (primer sets from the 5#UTR) revealed that CTN-
RNA was present in the cells even after prolonged tran-
scription inhibition, suggesting a low turnover (Figure
2C, upper panel). However, the mCAT2 mRNA tran-
scribed from promoter E completely turned over within
6 hr of transcription inhibition (Figure 2C, lower panel;
see also below), demonstrating the differential stability
of CTN-RNA and protein-coding mCAT2 mRNA.
CTN-RNA Localizes to Paraspeckles and Is
in a Complex with PSP1  and p54nrb
In order to determine whether CTN-RNA localizes to a
known nuclear domain, we performed simultaneous
RNA-FISH and immunolocalization using antibodiesCell
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Figure 2. CTN-RNA and mCAT2 mRNA Are Transcribed from the mCAT2 Gene
(A) Diagram of the genomic region of the mCAT2 gene on mouse chromosome 8A4. CTN-RNA is transcribed from the mCAT2 gene, which
also encodes the protein-coding mCAT2 mRNA. The light gray boxes (1A to 1E) represent the multiple promoters of the mCAT2 gene, each
containing a unique 5#UTR (exon 1). CTN-RNA is transcribed from promoter A, has unique 5# and 3#UTRs, and utilizes the distalmost poly(A)
site (AATAAA). mCAT2 mRNA is predominantly transcribed from promoter D in macrophages and E in mouse liver and utilizes the proximal
poly(A) site. The black boxes represent exons, and the lines between the black boxes depict intronic regions. The hatched boxes represent
CpG islands. The dark gray boxes in each of the RNAs represent the unique 5# and 3#UTRs.
(B) Northern blot analysis of total RNA from C127I cells using an exon 11 probe detects both the w8 kb CTN-RNA and the w4.2 kb
mCAT2 mRNA.
(C) CTN-RNA is a stable RNA. cDNA was prepared from RNA of untreated (control) and  -amanitin-treated cells ( -amanitin, 3 hr post
washout, and 9 hr post washout; see Experimental Procedures for details). RT-PCR was carried out with specific primers from the 5#UTRs of
CTN-RNA or mCAT2 mRNA.
against protein members of known nuclear domains in
wt MEFs (Figure S5). Dual labeling of CTN-RNA (red;
Figure S5E) and the nuclear speckle protein SF2/ASF
(green; Figure S5E#) revealed that some of the CTN-
RNA foci were located at the periphery of the SF2/ASF-
positive speckles and showed partial overlap (Figure
S5E$; see yellow signal in the higher-magnification in-
set in Figure S5E%). This finding is consistent with the
fact that our cDNA library was generated from the
RNAs of IGCs and associated nuclear compartments.
Recently, Lamond and colleagues identified a nuclear
domain, paraspeckles, localized adjacent to nuclearRegulating Gene Expression by RNA Nuclear Retention
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Figure 3. CTN-RNA Localizes to Paraspeckles
(A) RNA-FISH using CTN-RNA probe (red, Aa) in wt MEF cells transiently transfected with YFP-PSP1  (Ab) showed complete colocalization
of CTN-RNA and PSP1  in paraspeckles (Ac). Scale bar equals 5  m.
(B) Immunoprecipitation (IP) from YFP-PSP1  stably expressing NIH 3T3 cells using anti-GFP antibody or anti-HA (( ) IP) antibody. Arrow in
(B) and (E) denotes IgG.
(C) RT-PCR from the IP using CTN-RNA-specific primers showed amplification only in the GFP-IP sample and not ( ) IP, revealing a specific
interaction of CTN-RNA and YFP-PSP1  protein (Ca). RT-PCR using GAPDH mRNA-or U6 snRNA-specific primers from the above IP sample
showed no amplification (Cb).
(D) RNA-FISH using CTN-RNA probe (red, Da) in wt MEF cells transiently transfected with T7-p54nrb (green, Db) showed complete colocaliza-
tion of CTN-RNA and T7-p54nrb in paraspeckles (Dc). Scale bar equals 5  m.
(E) Immunoprecipitation from NIH 3T3 cells transiently transfected with T7-p54nrb using anti-T7 antibody or anti-HA (( ) IP).
(F) RT-PCR from the IP using CTN-RNA-specific primers showed amplification only in the T7-IP sample and not ( ) IP.
speckles (Fox et al., 2002). Paraspeckles range in num-
ber from 10 to 20 per nucleus, are present in primary
and transformed cells, and contain paraspeckle protein
1 (PSP1  and  ), PSP2, p54nrb, and cleavage factor 1m
68 (CF 1m68) (Dettwiler et al., 2004; Fox et al., 2002).
All of these proteins possess characteristic RNA rec-
ognition motifs (RRMs). Detailed analysis of CTN-RNA
localization by RNA-FISH in wt MEF cells expressing
YFP-PSP1  showed complete colocalization at para-
speckles (Figures 3Aa–3Ac). Furthermore, by using
anti-GFP antibodies, we immunoprecipitated the YFP-
PSP1 -containing RNP complex from NIH 3T3 cells
stably expressing YFP-PSP1  (Figure 3B). Total RNA
was isolated from the immunoprecipitate (IP), and RT-
PCR was carried out using CTN-RNA-specific primers
(Figure 3Ca). However, YFP-PSP1  did not immuno-
precipitate GAPDH mRNA or U6 snRNA, ruling out non-
specific interactions (Figure 3Cb). These results re-
vealed that PSP1  interacts with CTN-RNA. Similarly,
p54nrb/NonO also colocalized with CTN-RNA at para-
speckles, as evident by T7 antibody labeling in T7-
p54nrb transiently transfected wt MEF cells (Figures
3Da–3Dc). In addition, immunoprecipitation using a T7
antibody from NIH 3T3 cells transiently transfected with
T7-p54nrb (Figure 3E) followed by RT-PCR with CTN-
RNA-specific primers showed specific interaction of
p54nrb and CTN-RNA (Figure 3F). The colocalization, as
well as the IP results of PSP1  and p54nrb with CTN-
RNA, confirms the interaction of paraspeckle proteins
and CTN-RNA. Furthermore, double-label immunogold
electron-microscopic analysis of NIH 3T3 cells stably
expressing YFP-PSP1  showed that paraspeckles are
highly enriched with RNA molecules (Figure S6). In ad-
dition, paraspeckles were sensitive to RNase A but not
DNase I pretreatment, suggesting a role for RNA in
maintaining the structural integrity of paraspeckles
(Figures S7 and S8).
CTN-RNA Is A-to-I Edited in Its 3 UTR
RNAs such as Xist and hsr- -n as well as the newly
identified CTN-RNA are retained in the nucleus even
after they are properly processed (reviewed, Szymanski
and Barciszewski, 2003 and the present study). How-
ever, the mechanism or mechanisms by which these
RNAs are retained in the nucleus are not clear. Post-
transcriptional modification of adenosine (A) residues
to inosine (I) within RNAs, known as A-to-I editing (re-
viewed, Bass, 2002), has been suggested to be one of
the mechanisms of nuclear retention of RNAs. Multiple
I residues in the edited RNA have been shown to in-Cell
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teract with a protein complex comprised of p54nrb, PSF,
and matrin 3, resulting in the retention of this RNP com-
plex in the nucleus (Zhang and Carmichael, 2001).
Adenosine deaminase acting on RNA (ADAR) enzymes
catalyze the A-to-I editing of RNA and recognize the
double-stranded regions of the RNA for their activity
(reviewed, Bass, 2002). The finding that p54nrb is pres-
ent in paraspeckles and is involved in retaining A-to-I
edited RNAs in the nucleus and our finding that CTN-
RNA interacts with p54nrb raised the possibility that
CTN-RNA might be a target for RNA editing. Consistent
with this possibility, immunolocalization studies in wt
MEFs using an antibody against PSF revealed that it
colocalized with YFP-PSP1  in paraspeckles, further
strengthening the link between RNA editing and para-
speckles (Figure S9).
Sequence analysis of the entire w8 kb CTN-RNA
transcript revealed that there is a w100 nucleotide re-
gion (forward repeat) in the 3#UTR that is present as
three inverted repeats of SINE origin further down-
stream (Figure 4A). Each of these inverted repeats can
form an imperfect stem loop with the forward repeat,
which is a characteristic target site for recognition by
the ADAR enzymes. Sequence comparison of several
mouse liver CTN-RNA cDNA clones with the genomic
DNA sequence revealed that inverted repeat 2 and its
immediate 3# region contained 3 A residues that exhib-
ited A-to-I editing. Quite strikingly, the forward repeat,
which is present in both mCAT2 mRNA and CTN-RNA,
showed hyperediting only in CTN-RNA (4–9 A residues
in various cDNAs; Figure 4B). A-to-I editing in the CTN-
RNA 3#UTR and its interaction with p54nrb suggest that
editing could be a possible mechanism of nuclear re-
tention of CTN-RNA.
Reporter Analysis of the CTN-RNA 3 UTR
The 3#UTRs of RNAs have been shown to contain se-
quence elements that regulate RNA localization and
stability (Mignone et al., 2002). In order to address the
role of the 3#UTR of CTN-RNA in its nuclear retention,
we developed an in vivo reporter assay. A mammalian
vector containing a plasma-membrane targeting signal
fused to cyan fluorescent protein (MEM-CFP) was
fused to either the 3#UTR of the mCAT2 mRNA (MEM-
CFP-mCAT2 3#UTR; Figure 5Aa) or the entire 3#UTR of
CTN-RNA, which includes the 4.5 kb sequence down-
stream of the mCAT2 3#UTR (MEM-CFP-CTN-RNA
3#UTR; Figure 5Ab). In the latter construct, we deleted
the first poly(A) site so that only the distal poly(A) site
of CTN-RNA was utilized. Mouse NIH 3T3 cells were
transiently transfected with either the vector alone
(MEM-CFP-vector), MEM-CFP-mCAT2 3#UTR, or MEM-
CFP-CTN-RNA 3#UTR, and the localization of CFP was
monitored 24 hr posttransfection. In the vector control
as well as in cells transfected with MEM-CFP-mCAT2
3#UTR, the reporter CFP properly expressed and local-
ized to the plasma membrane (Figures 5B, 5C, and 5E).
However, cells transfected with MEM-CFP-CTN-RNA
3#UTR expressed very low levels of CFP protein (Fig-
ures 5D and 5E), although CFP mRNA was expressed
(Figure 5F), demonstrating that the CTN-RNA 3#UTR
contains elements that restrict the translation of CTN-
RNA. Surprisingly, in a population of transfected cells,
the reporter RNA showed a homogenous nuclear and
cytoplasmic localization (data not shown). One of the
possibilities is that the overexpression of the reporter
construct, driven by the CMV promoter, limits the quan-
tities of factors involved in nuclear RNA retention/sta-
bility. Alternatively, the 3#UTR of CTN-RNA is essential
but not sufficient for nuclear retention. To substantiate
this possibility, the entire w8 kb CTN-RNA was cloned
into a mammalian expression vector and transfected
into human IMR-90 cells, and RNA-FISH was carried
out to detect CTN-RNA in this heterologous system,
taking advantage of the fact that the CTN-RNA probe
does not crosshybridize to human cells. RNA-FISH re-
vealed that the entire w8 kb transcript showed nuclear
localization, whereas the construct lacking the CTN-
RNA-specific 3#UTR shows entirely cytoplasmic distri-
bution (data not shown). These results suggest that the
nuclear retention of CTN-RNA is a consequence of spe-
cific folding of the entire RNA as well as A-to-I editing
in its 3#UTR.
CTN-RNA Regulates Its Protein-Coding
Partner, mCAT2 mRNA
To address the functional significance of CTN-RNA, we
used antisense oligonucleotides to knock down CTN-
RNA in mouse mammary tumor (C127I) and macrophage
(RAW264.7) cell lines. Several antisense oligonucleotides
were designed from the unique CTN-RNA-specific
5#UTR (exon 1A) and 3#UTR (nonoverlapping region
with mCAT2 mRNA 3#UTR) in order to specifically tar-
get CTN-RNA. Two independent oligonucleotides,
AS109 and AS113 from the CTN-RNA 3#UTR, showed
>80% knockdown of CTN-RNA as quantified by Q-PCR
using CTN-RNA-specific primers from the 5#UTR (Fig-
ure 6A and Figure S10). Control oligonucleotides (sense
or scrambled) did not show any knockdown of CTN-
RNA (Figure 6A). BrdU incorporation studies did not
show any difference between cells exposed to sense
or antisense molecules, suggesting a normal cell-cycle
progression (Figures S11C and S11D). Although RNase
A treatment disrupted paraspeckles, NIH 3T3 cells sta-
bly expressing YFP-PSP1  and treated with CTN-RNA
antisense oligonucleotides did not show any disorgani-
zation of YFP-PSP1 -containing paraspeckles (Figures
S11E and S11E#). This result suggests either that the
low levels of CTN-RNA retained in the antisense-oligo-
nucleotide-treated cells are sufficient to provide a
structural framework to paraspeckles or that CTN-RNA
is not a structural RNA and localizes in paraspeckles
due to its modification.
Surprisingly, C127I cells that were treated with CTN-
RNA-specific antisense oligonucleotides also exhibited
knockdown of mCAT2 mRNA (>50%) as observed by
Q-PCR using specific primer pairs from the mCAT2
mRNA-specific exon 1E 5#UTR (Figure 6B). Similarly,
two additional antisense oligonucleotides that were de-
signed from the 5#UTR of CTN-RNA (exon 1A; AS713
and AS716) resulted in the knockdown of CTN-RNA and
in addition elicited knockdown of mCAT2 mRNA (Figure
6C). However, general transcription in cells treated with
antisense oligonucleotides to CTN-RNA, as observed
by BrUTP incorporation studies (Figures S11A and
S11B) as well as by RT-PCR (actin and NOS2; FigureRegulating Gene Expression by RNA Nuclear Retention
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Figure 4. CTN-RNA Is A-to-I Edited
(A) Schematic representation of CTN-RNA and mCAT2 mRNA. Sequence analysis of CTN-RNA revealed a w100 nt fragment in the 3#UTR
overlapping the mCAT2 mRNA and the CTN-RNA, which is present as three inverted repeats of SINE origin further downstream in the 3#UTR
unique to CTN-RNA (Inverted Repeats 1 to 3). These inverted repeats can form imperfect stem loops with the w100 nt region.
(B) Sequence blast analysis of several cDNA clones of CTN-RNA from mouse liver and their comparison with the genomic DNA sequence
revealed multiple residues showing A-to-I editing in the forward repeat. The adenosine (A) in the pre-mRNA is converted to inosine (I), which
is structurally similar to guanosine (G), by the ADAR enzyme and, during the first-strand cDNA synthesis, is incorporated as cytosine (C).
Subsequently, in the second-strand synthesis, this C complements to form G, which is what is observed in the cDNA instead of A. The edited
residues are denoted in lowercase.
S10), was unaffected as compared to cells treated with
the sense oligonucleotide. Therefore, the knockdown
of CTN-RNA specifically correlates with the loss of the
protein-coding mCAT2 mRNA, suggesting a positive
role for CTN-RNA in regulating the stability and/or ex-
pression of mCAT2 mRNA.
To define the specific region of CTN-RNA that regu-
lates the stability of the mCAT2 mRNA, we have gener-
ated several stable cell lines with reporter constructs
(MEM-CFP) containing different regions of CTN-RNA
under the control of the endogenous CTN-RNA pro-
moter (Figure 6D). In these cells, endogenous CTN-RNA
was knocked down using specific antisense oligonu-
cleotides, and the levels of mCAT2 mRNA were deter-
mined by Q-PCR using mCAT2 mRNA-specific primers.
The results showed that cell lines expressing reporter
constructs containing the common mCAT2 3#UTR (Fig-
ures 6D and 6E; constructs 2, 3, and 4) rescued the
mCAT2 mRNA downregulation, though the endogenous
CTN-RNA was efficiently knocked down by the anti-
sense oligonucleotides. These results clearly demon-
strate that the w1.5 kb 3#UTR region (common to
mCAT2 and CTN-RNA) is critical for the stability of the
mCAT2 mRNA.
CTN-RNA Is Posttranscriptionally Cleaved
upon Cellular Stress
The mCAT2 protein is a cell-surface receptor involved
in the cellular uptake of L-arginine, which is a precursor
for the synthesis of nitric oxide (NO). The NO pathway
is induced in cells under various stress conditions, in-
cluding viral infection and wound healing, as a part of a
cellular defense mechanism (reviewed, Lowenstein and
Padalko, 2004). The relative abundance of nuclear-
retained CTN-RNA over mCAT2 mRNA in unstressed
cells suggests a critical role for CTN-RNA in possibly
providing a quick cellular response during stress. One
model posits that CTN-RNA could serve as an interme-
diary for the rapid production of mCAT2 protein via
posttranscriptional cleavage of the 3#UTR of CTN-RNA.
This would release the protein-coding mRNA for trans-
port to the cytoplasm. In situ hybridization using a
probe that recognizes both CTN-RNA and mCAT2
mRNA showed predominant nuclear labeling (Figure
7Aa). When cells were stressed by inhibiting RNA poly-
merase II transcription with  -amanitin or DRB (data
not shown), decreased nuclear and increased cytoplas-
mic labeling was observed as compared to untreated
cells (compare Figures 7Aa and 7Ba). In addition, para-Cell
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Figure 5. Reporter Analysis Using the CTN-RNA 3#UTR
(A) A mammalian expression vector encoding a membrane targeting signal at the amino terminus of CFP was fused to either the 3#UTR of
the mCAT2 mRNA (Aa) or the 3#UTR of the CTN-RNA (Ab), which includes a w4.5 kb sequence downstream of the mCAT2 3#UTR.
(B–D) Mouse NIH 3T3 cells were transiently transfected with either the MEM-CFP-vector alone (B), MEM-CFP-mCAT2 3#UTR (C), or MEM-
CFP-CTN-RNA 3#UTR (D). Expression and localization were monitored 24 hr posttransfection. DNA is stained with 7-AAD. Scale bar equals
5  m.
(E) Immunoblot analysis using anti-GFP antibody in NIH 3T3 cells transiently transfected (24 hr) with the above constructs. The vector alone
and mCAT2 3#UTR-containing constructs showed expression of the GFP reporter, whereas the construct containing the CTN-RNA 3#UTR
showed extremely low levels of GFP protein.  -tubulin was used as loading control.
(F) Total RNA was isolated from NIH 3T3 cells transiently transfected with the above plasmid constructs and RT-PCR carried out using
CFP primers.
speckle labeling of CTN-RNA was abolished. Addition
of IFN  + LPS post  -amanitin treatment further in-
creased the cytoplasmic labeling, concomitant with re-
duced nuclear labeling (Figure 7Ca). Northern analysis
using an exon probe (hybridizing to both CTN-RNA and
mCAT2 mRNA) further demonstrated that in untreated
cells there is w2-fold more CTN-RNA than mCAT2
mRNA (Figure 7D, lane 2). Furthermore, cells treated
with  -amanitin followed by IFN  + LPS showed a sig-
nificant decrease in the level of w8 kb CTN-RNA, with
a concomitant increase in the w4.2 kb mRNA (Figure
7D, lane 3). Similarly, Northern blot hybridization using
a CTN-RNA 5#UTR oligonucleotide probe predomi-
nantly hybridized to the w8 kb band in unstressed cells
(Figure 7E, lane 2). In  -amanitin-treated cells as well
as in cells treated with  -amanitin followed by IFN  +
LPS, the CTN-RNA 5#UTR probe now showed an in-
creased hybridization signal at w4.2 kb, with a con-
comitant decrease in w8 kb signal (Figure 7E, lanes 1
and 3). Furthermore, the mCAT2-specific 5#UTR probe
hybridized to a w4.2 kb band only in untreated cells
and not in either  -amanitin-treated cells or cells
treated with  -amanitin followed by IFN  + LPS, corrob-
orating the Q-PCR results (Figures 7F and 7G). Finally,
Q-PCR analysis to evaluate the levels of CTN-RNA in
cells treated with  -amanitin or  -amanitin followed by
IFN  + LPS, using two independent primer pairs from
CTN-RNA (5#UTR exon 1A and unique 3#UTR), de-
tected fewer transcripts containing the 3#UTR, corrob-
orating the cleavage of CTN-RNA to release the pro-
tein-coding mRNA (Figure 7H). These observations
demonstrate that, under stress conditions, the w8 kb
CTN-RNA is posttranscriptionally cleaved at its 3#UTR,
releasing a protein-coding message for transport to
the cytoplasm.
In order to address whether the cleaved CTN-RNA
product is translation competent, we carried out repor-
ter analysis since there is no mCAT2 antibody available.
The CTN-RNA or mCAT2 mRNA 3#UTRs were cloned
downstream of a MEM-CFP reporter, which is under the
control of the SV2 promoter. In unstressed cells, the
CTN-RNA 3#UTR reporter did not get translated even
though it is efficiently transcribed (Figure 8A, lane 3 and
Figure S12E). However, upon addition of IFN  + LPS,
reporter protein was detected (Figure 8A, lane 4) and
localized to the plasma membrane (Figure S12F). TheRegulating Gene Expression by RNA Nuclear Retention
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Figure 6. CTN-RNA Regulates Its Protein-Coding Partner, mCAT2 mRNA
(A) Antisense oligonucleotides designed from the unique 3#UTR of CTN-RNA (AS109 and AS113) were used to knock down CTN-RNA in
C127I cells. 80% knockdown of CTN-RNA was achieved as assessed by Q-PCR (see histogram). Control sense oligonucleotides (S109 and
S113) or scrambled oligonucleotides (SCR.OLIGO) had no effect.  -actin was used as loading control. CTN-RNA or mCAT2 mRNA levels were
normalized to  -actin mRNA and are presented relative to RNA levels in mock-transfected cells (histograms [A], [B], and [C]). The data in
(A)–(C) and (E) are shown as mean and standard deviation values of three measurements per data point.
(B) Antisense oligonucleotide (AS109 and AS113) treatment, specific only to CTN-RNA, showed significant knockdown of mCAT2 mRNA
(w50%) when analyzed by Q-PCR using primers from the unique mCAT2 mRNA region (exon 1E of the 5#UTR).
(C) Antisense oligonucleotide (AS713 and AS716) treatment specific only to CTN-RNA (5#UTR exon 1A) showed significant knockdown of
mCAT2 mRNA (w50%) when analyzed by Q-PCR.
(D) To define the specific region of CTN-RNA that is important for the stability of the mCAT2 mRNA, several stable cell lines expressing
different regions of CTN-RNA with reporter constructs (MEM-CFP) under the control of the endogenous CTN-RNA promoter were generated
(constructs 1–5).
(E) mCAT2 mRNA downregulation is rescued by the common mCAT2 mRNA and CTN-RNA 3#UTR. Cell lines containing constructs 1–5 were
treated with CTN-RNA-specific antisense oligonucleotides from either 5#UTR (AS716) or 3#UTR (AS109) individually, and the levels of endoge-
nous CTN-RNA and mCAT2 mRNA were monitored by Q-PCR (see table). Note: AS oligos targeting only the endogenous CTN-RNA were
used in each cell line. NA, not applicable.Cell
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Figure 7. CTN-RNA Is Posttranscriptionally Cleaved to Produce Protein-Coding mRNA in Response to Cellular Stress
(A–C) RNA-FISH to wt MEFs using an exon probe common to CTN-RNA and mCAT2 mRNA. In untreated cells (A), the RNA signal is predomi-
nantly nuclear with some cytoplasmic localization. Upon transcriptional inhibition, the nuclear labeling decreases, concomitant with an in-
crease in the cytoplasmic labeling (compare [A] and [B]). Transcriptional inhibition followed by IFN  + LPS treatment further decreases the
nuclear labeling (C). DNA was stained with DAPI (Ab, Bb, and Cb). Scale bar equals 5  m.
(D) Northern blot analysis using the common-exon-specific probe revealed that, in untreated cells, the w8 kb CTN-RNA transcript is in 2-fold
excess of the w4.2 kb mCAT2 mRNA. Treatment with  -amanitin followed by IFN  + LPS showed a decrease in CTN-RNA, concomitant with
an increase in the w4.2 kb transcript, the latter being in 2-fold excess as compared to former. Asterisk denotes mCAT2 mRNA in lane 2 and
cleaved w4.2 kb RNA in lanes 1 and 3. Ethidium-bromide-stained gel showing the levels of 28S and 18S rRNAs as loading control ([D], [E],
and [F]).
(E) Northern blot analysis using CTN-RNA 5#UTR-specific oligonucleotide probe (exon 1A) showed that it predominantly hybridized to w8 kb
CTN-RNA in untreated cells (lane 2). Treatment with  -amanitin and  -amanitin followed by IFN  + LPS showed a dramatic increase in signal
at w4.2 kb, with a concomitant decrease in w8 kb (compare lanes 1 and 3 with lane 2).
(F) Hybridization using mCAT2 5#UTR-specific probe (exon 1E) showed the presence of mCAT2 mRNA only in untreated cells (lane 2).
(G) mCAT2 mRNA levels transcribed from promoter E were analyzed using primers from exon 1E of its 5#UTR and showed high turnover after
 -amanitin treatment. The data in (G) and (H) are shown as mean and standard deviation values of three measurements per data point.
(H) CTN-RNA levels were monitored by Q-PCR using primers designed from exon 1A (representing the unique 5#UTR) and the 3#UTR. Fewer
CTN-RNA transcripts with an intact 3#UTR were present in cells treated with  -amanitin or  -amanitin followed by IFN  + LPS.
percentage of cells positive for membrane localization
of the reporter also increased after IFN  + LPS treat-
ment (Figure 8B). These results demonstrate that the
reporter RNA containing the CTN-RNA 3#UTR is cleaved
in response to IFN  + LPS and becomes translation
competent. Furthermore, since all the reporter con-
structs are driven by the SV2 promoter, which does not
contain any IRE, and since there is no observed in-
crease in translation in constructs containing either
MEM-CFP alone (Figure 8A, lanes 1 and 2 and Figures
S12A and S12B) or mCAT2 3#UTR (Figure 8A, lanes 5
and 6 and Figures S12C and S12D), the increased
translation of the reporter RNA containing the CTN-
RNA 3#UTR upon IFN  + LPS treatment is clearly due
to posttranscriptional cleavage.
Discussion
Recent studies from many organisms have indicated
that the vast majority of the transcriptional output of
the respective genomes does not encode for protein
products. These RNA are speculated to play regulatory
roles (reviewed, Mattick, 2003; Suzuki and Hayashizaki,
2004), though it has been difficult to determine their
mechanism of action (reviewed, Mattick, 2003; Szy-
manski and Barciszewski, 2003). In the present study,Regulating Gene Expression by RNA Nuclear Retention
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Figure 8. Posttranscriptionally Cleaved CTN-RNA Is Translation Competent
NIH 3T3 cells were transiently transfected with SV2-MEM-CFP, SV2-MEM-CFP-CTN-RNA 3#UTR, and SV2-MEM-CFP-mCAT2 3#UTR. Expres-
sion and localization were monitored 24 hr posttransfection in untreated cells and cells treated with IFN  + LPS for 8 hr.
(A) Immunoblot analysis using anti-GFP antibody in the above assay. The vector alone (lanes 1 and 2) and mCAT2 3#UTR-containing con-
structs (lanes 5 and 6) showed similar expression levels of the GFP reporter in untreated and IFN  + LPS-treated cells. The construct
containing the CTN-RNA 3#UTR showed extremely low levels of GFP protein in untreated cells, but a significant increase of GFP was observed
after IFN  + LPS treatment (lanes 3 and 4).  -tubulin was used as loading control.
(B) Histogram depicting the percentage of cells positive for membrane-CFP localization in the above assay. Error bars indicate standard errors.
(C) Model of mCAT2 mRNA regulation by CTN-RNA. In unstressed cells (upper cell), the mCAT2 gene transcribes CTN-RNA (a and b) and
mCAT2 mRNA (c, blue) through alternative promoter and poly(A) site usage. CTN-RNA is nuclear retained and regulates the level of mCAT2
mRNA. Upon stress (lower cell), CTN-RNA is posttranscriptionally cleaved in its 3#UTR (d), and the released mRNA (f, red), similar to mCAT2
mRNA (e, blue), is transported to the cytoplasm and translated into mCAT2 protein. This mechanism provides a rapid response for the
production of mCAT2 protein to modulate the cellular uptake of L-arginine for the NO pathway.Cell
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we identified CTN-RNA, a nuclear-retained poly(A)+
RNA that is transcribed from the protein-coding mCAT2
gene. The 3#UTR of CTN-RNA contains elements that
retain this RNA in the nucleus, in part through A-to-I
editing, thereby inhibiting its translation. Knockdown
of CTN-RNA results in the downregulation of both
CTN-RNA and mCAT2 mRNA. Rescue experiments
demonstrated that a common region of the 3#UTR of
CTN-RNA and mCAT2 mRNA contains an element or
elements that govern mCAT2 mRNA stability. Most in-
terestingly, upon cellular stress, CTN-RNA is posttran-
scriptionally cleaved to release a translation-competent
mRNA, thereby revealing an important cellular mecha-
nism for the rapid production of protein-coding mRNAs.
CTN-RNA Is a Member of the Nuclear Regulatory
RNA (nrRNA) Family
Typically, nascent pre-mRNAs of protein-coding genes
are processed at the site of transcription and are trans-
ported to the cytoplasm for translation. However, sev-
eral studies have shown that a significant population of
RNAs are retained within the nucleus and are sug-
gested to play structural roles or act as riboregulators
(Herman et al., 1976; Huang et al., 1994). The X chromo-
some-encoded nuclear-retained RNA, Xist (reviewed,
Plath et al., 2002), and its anti-sense transcript, Tsix
(Lee et al., 1999), are among the best studied nuclear
regulatory RNAs (nrRNAs) in mammalian cells.
Similar to the mCAT2 locus, the stress-inducible and
developmentally regulated hsr-  locus in Drosophila is
an example of a gene that transcribes two independent
transcripts from the same DNA strand (Hogan et al.,
1994). A longer transcript, hsr- -n RNA (w10–14 kb), is
an unspliced, polyadenylated nuclear-retained tran-
script suggested to regulate the intranuclear trafficking
of various hnRNPs (Prasanth et al., 2000). A shorter 1.2
kb transcript, hsr- -c RNA, is transcribed from the
same promoter as hsr- -n RNA but uses the proximal
poly(A) site. The hsr- -c RNA is spliced and polyadeny-
lated and, although it localizes in the cytoplasm, does
not encode for a protein (Fini et al., 1989). The nuclear
distribution of CTN-RNA suggests that it is a previously
unidentified member of the nrRNA family.
The 3 UTR of CTN-RNA Is Essential
for Nuclear Retention
The mechanisms underlying nuclear retention of RNA
are not well understood. However, A-to-I editing of RNA
is postulated to be one such mechanism (Zhang and
Carmichael, 2001). Biochemical purification studies
using in vitro-transcribed RNAs (containing viral se-
quences) that are A-to-I edited revealed that they co-
purify with p54nrb, PSF, and matrin 3 as a complex, and
it has been suggested that this p54nrb complex is in-
volved in the nuclear retention of hyperedited RNAs
(Zhang and Carmichael, 2001). Sequence comparison
of CTN-RNA cDNAs from mouse liver against genomic
DNA showed A-to-I editing at multiple residues in the
CTN-RNA 3#UTR. The interaction of CTN-RNA with a
p54nrb-containing RNP complex further suggests that
A-to-I editing of CTN-RNA facilitates its nuclear reten-
tion. Our finding that p54nrb and PSF localize to para-
speckles suggests that paraspeckles may serve as a
depot for sequestering A-to-I-edited nuclear RNAs. The
intense labeling of paraspeckles by colloidal-gold-con-
jugated RNase T1 (RNase T1 cleaves RNA 5# to G or
I with maximum efficiency; Morse and Bass, 1997) is
consistent with the possibility of edited RNAs being
present in paraspeckles.
Recently, several studies using computational as well
as experimental approaches have shown that more
than w1700 new candidate human RNAs are potentially
A-to-I edited (Athanasiadis et al., 2004; Kim et al., 2004;
Levanon et al., 2004; Morse et al., 2002). In most cases,
the editing was confined to the noncoding region of
the mRNA (5#UTR, 3#UTR, or introns) and the edited
structures were moderately repetitive sequences, in-
verted repeats predominantly of Alu origin. Our descrip-
tion of A-to-I editing in the Alu-like SINE repeats in the
3#UTR of CTN-RNA demonstrates that like in humans,
the editing machinery shows a similar preference for
repeats in the UTRs of mice. Our results elucidate CTN-
RNA as the first endogenous nuclear-retained RNA that
is hyperedited in its 3#UTR. This nuclear retention is
involved in the regulation of mCAT2 gene expression,
in contrast to previous studies suggesting that hyper-
edited viral RNAs are retained in the nucleus for degra-
dation (Kumar and Carmichael, 1997; Zhang and Car-
michael, 2001). It would be critical to evaluate whether,
like CTN-RNA, the above-mentioned edited RNAs are
nuclear retained and whether paraspeckles serve as a
depot for such RNAs.
Regulation of mCAT2 mRNA by CTN-RNA
Interestingly, knockdown of CTN-RNA using antisense
oligonucleotides designed from the unique 5# or 3#UTR
of CTN-RNA also resulted in the downregulation of
mCAT2 transcripts, suggesting that the nuclear-retained
CTN-RNA positively regulates the levels of the protein-
coding mCAT2 mRNA. Furthermore, rescue experi-
ments revealed that the 3#UTR sequence common to
mCAT2 mRNA and CTN-RNA was regulating the sta-
bility of mCAT2 mRNA. This regulation may occur
through the sequestration of a certain factor or factors
that are involved in the stability of mCAT2 mRNA by
this 1.5 kb region of the CTN-RNA 3#UTR. Since mCAT2
mRNA and CTN-RNA share this region, they could
compete for binding of such a factor or factors. Also, it
is important to note in this context that CTN-RNA is
more abundant than mCAT2 mRNA in unstressed cells
and thus may more efficiently sequester such a factor
or factors. Thereby, the knockdown of CTN-RNA may
allow access of this factor or these factors to the
mCAT2 transcripts, resulting in their degradation. An
example of such regulation has been reported for the
mouse Makorin1 gene (Hirotsune et al., 2003). Makorin1
pseudogene transcripts were proposed to be essential
for the stability of Makorin1 mRNA by providing a
means of sequestering destabilizing factors through di-
rect competition. Similar to the mCAT2 locus, studies
using high-density oligonucleotide arrays of human
chromosomes 21 and 22 revealed the existence of sub-
populations of coordinately regulated coding and non-
coding transcripts from the same genomic region (Caw-
ley et al., 2004). Future studies will determine whether
these RNAs are regulated in a similar manner and willRegulating Gene Expression by RNA Nuclear Retention
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elucidate the factor or factors that are involved in the
coordinate regulation of these transcripts.
The protein product of mCAT2 mRNA is a member of
the cationic amino acid transporter family of proteins
involved in the uptake of extracellular arginine, which
is essential for sustained NO production via nitric oxide
synthase 2 (NOS2) (Nicholson et al., 2001; Stevens et
al., 1996). Overproduction of NO has been shown to
play a pivotal role in inflammatory responses (Hier-
holzer et al., 1998). Persistent activation of NOS2 can
lead to the production of toxic levels of NO, resulting in
several diseases, including multiple sclerosis, Hunting-
ton’s disease, and Parkinson’s disease (Lee et al.,
2003). It was previously reported that interleukin 10,
which is an anti-inflammatory cytokine, attenuated the
induction of NO by inhibiting mCAT2 expression (Huang
et al., 2002). Furthermore, lack of L-arginine in cells re-
sults in the production of superoxide via the NOS2
pathway, resulting in cell death (Rosen et al., 2002). This
highlights the importance of cellular uptake of L-argi-
nine as a method of regulating inducible NO biosynthe-
sis. In addition, the tight regulation of the cellular up-
take of L-arginine is also governed by the CAT1 or
Slc7a1 gene (another cationic amino acid transporter).
CAT1 translational control is governed by the activity of
an internal ribosomal entry site (IRES) within the mRNA
leader (Yaman et al., 2003). mCAT1 is expressed in tis-
sues in a manner mutually exclusive of mCAT2. In cells
expressing mCAT2, the mCAT1 transcript is degraded
by miRNAs (miR-122), suggesting that a critical balance
is required for maintaining cellular homeostasis (Chang
et al., 2004). The present study has revealed a cell-
autonomous level of regulation whereby CTN-RNA dic-
tates the level of mCAT2 mRNA, thereby controlling the
cellular level of mCAT2 protein.
Posttranscriptional Cleavage of CTN-RNA: A Rapid
Response for Gene Expression
We have shown by RNA-FISH, Northern, and Q-PCR
analysis a precursor/product relationship between CTN-
RNA and mCAT2 mRNA when cells are subjected to
cellular stress. Our data demonstrate that the large ex-
cess of the nuclear-retained w8 kb CTN-RNA may act
as a storage form of the transcript until the cell en-
counters stress, upon which it gets cleaved posttran-
scriptionally to release a protein-coding mRNA (Figure
8C). As the cleaved transcript would not contain the
extended 3#UTR of CTN-RNA, which is involved in
nuclear retention and translation inhibition, it can be
exported to the cytoplasm and translated to produce
the mCAT2 protein. If the response were to start with
the initiation of transcription of mCAT2 upon stress, it
would take w25 min for RNA polymerase II to tran-
scribe the 24.5 kb mCAT2 gene. The posttranscripional
cleavage of CTN-RNA upon stress ensures that the cell
can act rapidly by producing mCAT2 protein that is
essential for NO production.
Although cleavage and polyadenylation of nascent
pre-mRNA is generally believed to commence co-
transcriptionally (reviewed, Colgan and Manley, 1997;
Proudfoot, 2004), our results suggest that some tran-
scripts such as CTN-RNA can be posttranscriptionally
cleaved upon stress. Interestingly, a recent study showed
that CF 1m68, involved in the early stages of pre-mRNA
cleavage, localizes to paraspeckles, suggesting a pos-
sible involvement of paraspeckles in this process (Dett-
wiler et al., 2004). Though the exact site of cleavage is
not defined, based upon the size of the cleaved tran-
script, it is likely that cleavage occurs in the common
3#UTR. Longer exposure of the Northern blot reveals a
smeared signal below the 4.2 kb region in stressed
cells, suggesting that there is not a single cleavage
point and therefore that cleavage may occur at multiple
closely positioned points. In light of our results from
unstressed cells, we would predict that cleavage oc-
curs upstream of the potential binding site of a destabi-
lization factor or factors.
The cell nucleus is usually thought of as an active
environment involved in processes such as transcrip-
tion, RNA processing, and DNA replication. We have
revealed a novel role of the cell nucleus in harboring
RNA molecules that are not immediately needed to pro-
duce proteins but whose cytoplasmic presence is rap-
idly required upon physiologic stress or other cellular
signals (Figure 8C). Such a role is analogous to the
presence of some transcription factors in the cyto-
plasm, such as the glucocorticoid receptor, which is
rapidly imported into the nucleus to initiate transcrip-
tion upon a cellular signal (reviewed, Hager et al., 2004).
The rapid response mechanism of nuclear RNA release
for protein synthesis elucidated in our study may be a
general paradigm for the production of some critical
regulatory proteins.
Experimental Procedures
cDNA Constructs
Mouse liver IGCs were isolated (Mintz et al., 1999) and poly(A)+
RNA was purified by passing total IGC RNA (isolated using Tri re-
agent; Molecular Research Center, Inc., Cincinnati) through oligo
dT columns (Stratagene, La Jolla, California). A plasmid-based
cDNA library was constructed from poly(A)+ RNA using the pBlue-
script II XR cDNA library kit as per the manufacturer’s instructions
(Stratagene). The complete CTN-RNA cDNA was identified with the
help of RT-PCR (RT primers designed from the original w700 bp
CTN-RNA 3#UTR) as well as by analyzing EST clones upstream of
the 700 bp 3#UTR region. Finally, the complete CTN-RNA was
cloned and sequenced (NCBI Accesion Number DQ086834). Re-
porter constructs containing various regions of CTN-RNA were de-
signed as described in Supplemental Experimental Procedures.
Cell Culture and Drug Treatments
wt MEF, C127I, and RAW264.7 cells were grown in DMEM contain-
ing high glucose (Invitrogen, Carlsbad, California) supplemented
with penicillin-streptomycin and 10% fetal bovine serum (FBS;
Hyclone Laboratories, Logan, Utah). NIH 3T3 cells were grown in
DMEM plus 10% calf serum. Cells were electroporated using 2  g
of plasmid DNA plus 40  g of salmon-sperm DNA (Amresco, Solon,
Ohio) and were seeded onto acid-washed coverslips and pro-
cessed for immunofluorescence localization or RNA in situ hybrid-
ization (Spector et al., 1998).
To inhibit RNA polymerase II transcription, murine cells were in-
cubated with  -amanitin (50  g/ml; Sigma, St. Louis) for 6 hr at
37°C.
Antisense-Oligonucleotide Treatment
Synthesis and purification of phosphorothioate-modified oligo-
deoxynucleotides (AS109, GTTTGCTCGCTAGTCAAAT; AS113, TCT
TGGTGATGTACTGCTC; AS713, CAGTGCCCTGGCCGCGCGAC;
AS716, CGCAGACAGAAGCTCCCGCC) were performed using an
Applied Biosystems 380B automated DNA synthesizer as describedCell
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previously (McKay et al., 1999). Oligonucleotides were adminis-
tered to C127I and RAW264.7 cells using Lipofectamine 2000 re-
agent as per the manufacturer’s instructions (Invitrogen). Optimal
Lipofectamine 2000/oligonucleotide ratios were empirically deter-
mined. Cells were incubated with a mixture of Lipofectamine 2000
and oligonucleotide in OptiMEM medium (Invitrogen) at 37°C, 5%
CO2. After 5 hr, the transfection mixture was aspirated from the
cells and replaced with fresh DMEM plus 10% FBS and incubated
at 37°C, 5% CO2 for 16–18 hr.
To induce mCAT2 mRNA and CTN-RNA expression, untreated or
oligonucleotide-treated cells were incubated with IFN  (50 units/ml;
Sigma) + LPS (100 ng/ml, Escherichia coli 055:B5; Sigma) for vari-
ous time points prior to the harvest of cells for RNA analysis.
RNA Fluorescence In Situ Hybridization
To detect CTN-RNA, cells were rinsed briefly in PBS and then fixed
in 2% formaldehyde in PBS (pH 7.4) for 15 min at RT. Cells were
permeabilized in PBS containing 0.5% Triton X-100 and 5 mM VRC
(New England Biolabs, Inc., Beverly, Massachusetts) on ice for 10
min. Cells were washed in PBS 3  10 min and rinsed once in 2 
SSC prior to hybridization. Hybridization was carried out using
nick-translated cDNA probes (nick-translation kit; VYSIS Inc.,
Downers Grove, Illinois) in a moist chamber at 37°C for 12–16 hr as
described earlier (Spector et al., 1998). For colocalization studies,
after RNA-FISH, cells were again fixed for 5 min in 2% formalde-
hyde, and IF and imaging were performed as described elsewhere
(Prasanth et al., 2003).
Cellular Fractionation and RNA-Protein-Complex
Immunoprecipitation
Nuclear and cytoplasmic fractionation and RNA isolation were de-
scribed previously (Topisirovic et al., 2003). NIH 3T3 cells tran-
siently transfected with a T7-p54nrb construct or stably expressing
YFP-PSP1  were used for immunoprecipitation. Lysates were pre-
pared as described previously (Platani et al., 2000). Following ly-
sate centrifugation, the supernatant was precleared and used for
IP using either HA, T7, or GFP antibodies. IP was carried out for
4 hr at 4°C. This was followed by 1 hr incubation with   bind G
Sepharose beads (Amersham Biosciences Corp., Piscataway, New
Jersey). Beads were washed five times in buffer B (Platani et al.,
2000). Half of the IP material was used for immunoblot analysis and
the other half for extraction of RNA from the IP using Tri reagent
(Molecular Research Center, Inc.). For RT-PCR, RNA isolated from
the IPs was DNase I treated and reverse transcribed using random
hexamers, and the resulting material was used for PCR amplifica-
tion using CTN-RNA-specific primer pairs.
Northern blot hybridization using random-labeled probes and im-
munoblotting were performed according to previously published
procedures (Janicki et al., 2004). Northern hybridization using oli-
gonucleotide probes (exon 1A) was performed as per manufactur-
er’s instructions (Ambion Inc., Austin, Texas).
RT-PCR and Q-PCR
RNA was isolated from cultured cells or mouse tissues using Tri
reagent solution according to the manufacturer’s instructions (Mo-
lecular Research Center, Inc.). For RNA analysis, equivalent amounts
of total RNA served as template for cDNA synthesis using reverse
transcriptase, followed by PCR using specific primers (Invitrogen).
For real-time quantitative PCR (Q-PCR), total RNA was isolated
using Tri reagent, treated with RNase-free DNase I (Invitrogen), and
converted to cDNA using the TaqMan Reverse Transcription Re-
agents (Applied Biosystems, Foster City, California). Gene-specific
TaqMan primer sets were designed using Primer 3 software (se-
quences are available from the authors upon request). Q-PCR was
carried out in triplicate using SYBR Green PCR Master Mix (Applied
Biosystems) on an ABI Prism 7700 Sequence Detector (Applied
Biosystems), and  -actin served as an endogenous normalization
control. Sequence Detector software (version 1.7) was utilized for
data analysis, and relative fold induction was determined by the
comparative threshold cycle method. The data are shown as mean
and standard deviation values of three measurements per data
point.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and 12 figures and can be found with this article online at http://
www.cell.com/cgi/content/full/123/2/249/DC1/.
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